Top Analyst Upgrades and Downgrades: Allstate, CalAmp, Chubb, Costco, Esperion, Flex, Hartford, Nio, Rockwell Automation, Roku and More

Print Email

Five Prime Therapeutics Inc. (NASDAQ: FPRX) was started as Neutral and assigned a $10 target price (versus $8.73 close) at Roth Capital. It has a $315 million market cap and a 52-week range of $7.84 to $18.55.

Flex Ltd. (NASDAQ: FLEX) was raised to Overweight from Neutral with a $12 price target at JPMorgan. Shares closed down 0.4% at $9.23, in a 52-week range of $6.74 to $15.38. The consensus analyst target is $14.07.

Forty Seven Inc. (NASDAQ: FTSV) was started as Buy and assigned an $18 target price (versus a $12.49 close) at Roth Capital.

General Mills Inc. (NYSE: GIS) was downgraded to Sell from Neutral at Goldman Sachs. Shares closed down 3.3% at $51.09. The stock has a 52-week range of $36.42 to $53.66 and a consensus target price of $50.20.

Global Blood Therapeutics Inc. (NASDAQ: GBT) was started as Neutral and assigned a $75 target price (versus a $60.97 close) at Goldman Sachs.

Granite Construction Inc. (NYSE: GVA) was raised to Buy from Neutral and the target price was raised to $53 from $50 (versus a $40.11 close) at Goldman Sachs.

Hartford Financial Services Group Inc. (NYSE: HIG) was raised to Buy from Neutral and the price target was raised to $64 from $53 at Goldman Sachs. Shares closed down 1.5% at $52.46, in a 52-week range of $40.54 to $54.28. The consensus target price is $58.24.

National Vision Holdings Inc. (NASDAQ: EYE) was started with a Buy rating and assigned a $38 target price (versus a $27.36 close) at Berenberg.

Nio Inc. (NYSE: NIO) was downgraded to Underperform from Neutral at Merrill Lynch. Shares closed up 3.6% at $4.00, in a 52-week range of $3.81 to $13.80. The consensus analyst target is $7.64.

Radius Health Inc. (NASDAQ: RDUS) was raised to Buy from Neutral and the target price was raised to $38 from $26 (versus a $21.23 close) at Goldman Sachs.

Rockwell Automation Inc. (NYSE: ROK) was raised to Buy from Hold with a $160 price target at Gabelli. Shares closed down 2.1% at $151.57. The 52-week range is $141.46 to $198.23, and the consensus target price is $178.15.

Roku Inc. (NASDAQ: ROKU) fell over 7% to $88.83 on Tuesday after a firm called Stephens downgraded its rating to Equal Weight based on more risk than implied reward. Roku was indicated up 1% at $89.70 after Needham raised its target to $120 (a street-high from analysts) from $85 based on unique advantages as an aggregator rather than as a streaming service that makes its own content too.

Total System Services Inc. (NYSE: TSS) was downgraded to Sector Weight from Overweight at KeyBanc Capital Markets.

UroGen Pharma Ltd. (NASDAQ: URGN) was started with a Neutral rating and assigned a $50 target price (versus a $36.49 close) at Goldman Sachs.

I'm interested in the Newsletter